Nasdaq

Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and ...
Nasdaq

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. “The first quarter of 2025 represents the ...
Seeking Alpha

Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion

Bionano is guiding for full-year 2026 revenue of $30 million to $33 million, representing 5% to 16% growth over 2025. Q1 2026 revenue guidance is $6.5 million to $6.7 million, described as "flat to 3% ...
Seeking Alpha

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of ...